Meta‐regression was used to investigate clinical and demographic factors affecting VEGF‐A levels and their association with disease progression in ALL, focusing on covariates including age, total sample size, publication year, male ratio, and NOS quality assessment score, as detailed in Table 2. The gene discussed is VEGFA; the disease is acute lymphoblastic leukemia.